Skip to content

PolitiKit

Lobbying by GlaxoSmithKline Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

GlaxoSmithKline Inc.

Meetings this Parliament
2
With MPs
0
Since Nov 2021
4
Active registrations
0

Most recent reported meeting: Nov 25, 2025.

Registrations in effect

GlaxoSmithKline Inc. has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.

Reported meetings

Spreadsheet
  • Reported by Alexander MacDonald · Consultant

    • Bailey Burton · Member of Parliament, House of Commons
    Renewal of national vaccine strategy to close gaps in vaccination coverage for Canadians, especially among seniors.

    Official report

  • Reported by Alexander MacDonald · Consultant

    • Steven Sternthal · Director General, Public Health Agency of Canada (PHAC)
    Renewal of national vaccine strategy to close gaps in vaccination coverage for Canadians, especially among seniors.

    Official report

  • Reported by Alexander MacDonald · Consultant

    • Cid Cabillan · Policy Advisor, Immigration, Refugees and Citizenship Canada (IRCC)

    Health

    Official report

  • Reported by Alexander MacDonald · Consultant

    • Connor MacDonald · Policy Advisor, House of Commons

    Economic DevelopmentHealthResearch and Development

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.